Ann: Half Year Report and Update, page-86

Hey @singhgu, the indication I was referring to is the COVID related trials
Those are the outsourced trials that I wouldnt hold my breath on
They need funding (either from partnership or CR) for kidney trials which I am agreeing would improve the SP

TBH, this will be unpopular, but the FSGS results are not very strong. 7 patients whose average response is likely driven by 1 or 2 patients based on the individual patient data shown thus far

DKD sub analysis communication has gone silent. The last couple decks have shed almost no light on a data-based explanation for why the placebo group performed well. so make of that what you will.

good luck.